FDA head Marty Makary explains why agency is pulling safety warnings for menopause hormone therapies
The Food and Drug Administration has approved removing safety warnings from several menopausal hormone therapy products. FDA ...
Richard Pazdur, a longtime regulator, said politics risks outweighing science at the agency.
With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...
After a closed-door hearing with Food and Drug Administration Commissioner Marty Makary, U.S. Senate Republicans are renewing ...
Newsmax on MSN
GOP senators blast FDA over abortion drug study
GOP Senators Blast FDA Over Abortion Drug Study ...
The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.
Novo Nordisk has also spoken out strongly against Hims & Hers' compounded Wegovy pill, with CEO Maziar Mike Doustdar telling ...
The head of the Food and Drug Administration (FDA) says that while the Trump administration is taking the potential harms of marijuana use among youth “very seriously,” it’s also important to preserve ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...
As commissioner of the U.S. Food and Drug Administration since March 2025, Dr. Marty Makary is responsible for greenlighting and regulating treatments, from drugs to vaccines. While some health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results